Product Description
The development and marketing of drugs since the Second World War offers an exemplary demonstration of the impact of technology on competitiveness in a major industry. While focusing primarily on the market in the USA, this study examines also the activities of European firms, their contribution to the industry’s technological evolution and the impact of their entry into the US market.
The main concern of the book, however, is to examine all the elements which go… More >>
Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry
#1 by A scientist/business person (hardyct@inav.net) on May 1, 2010 - 2:12 pm
This book started out extremely well, but the final two chapters left me with a negative impression of the text. The first five chapters are entitled: 1) Analyzing technology in an interactive environment, 2) Competition in the U.S. pharmaceutical industry today, 3) The foundations of the modern pharmaceutical industry, 4) Dynamic trends in the postwar era, 5) The structuring of the modern industry. If anything, the material presented in all five of these chapters is too condensed but very interesting.
The final two chapters are entitled: 6) Firm responses in a changing industry, 7) Forces in competition: past, present and future. The sixth chapter is awful, here the authors, both of them management researchers from different business colleges (neither with a background in science or medicine) analyzed nearly 20 years of inadequate data in a ridiculous way that was poorly presented. The seventh and final chapter was also disappointing. Someone should take the good material in this book as a template and write another book, especially in speculating about the future impact of biotechnology on the pharmaceutical industry. If I were you, I would get a good book on the history of the pharmaceutical industry, and make your own inferences about competitive forces.
Rating: 2 / 5